Neuehealth, INC Form 4 insider transactions

George Lawrence Mikan III, CEO and President of NeueHealth, Inc., reported the disposition of 58,877 common stock shares on March 6, 2025, following the vesting of restricted stock units.

Jeffrey J. Scherman, Chief Accounting Officer of NeueHealth, Inc., sold 1,368 shares of common stock to cover tax withholding obligations.

A NeueHealth executive sold 2,486 shares to cover tax obligations related to vesting restricted stock units.

NeueHealth's Chief Financial Officer, Jay Matushak, sold 4,970 shares of common stock to cover tax obligations related to vesting restricted stock units.

Tomas Orozco, EVP of Consumer Care at NeueHealth, sold 1,233 shares of common stock to cover tax obligations related to vesting restricted stock units.

NeueHealth CEO George Lawrence Mikan III sold 31,798 shares of common stock to cover tax obligations related to vesting restricted stock units.

Jeffrey J. Scherman, Chief Accounting Officer of NeueHealth, Inc., reported the acquisition of 3,640 shares of common stock through the vesting of restricted stock units.

NeueHealth's General Counsel and Corporate Secretary, Jeff Michael Craig, exercised stock options, acquiring 6,618 shares of common stock.

NeueHealth's Chief Financial Officer, Jay Matushak, executed a transaction involving restricted stock units, resulting in a change in his beneficial ownership of the company's stock.

EVP of Consumer Care at NeueHealth, Tomas Orozco, acquired 3,971 shares of common stock through the vesting of restricted stock units.

NeueHealth CEO George Lawrence Mikan III exercised 95,308 restricted stock units, converting them into common stock.

NeueHealth CEO George Lawrence Mikan III sold 16,803 shares of common stock to cover tax obligations after the vesting of restricted stock units.

Jay Matushak, CFO of NeueHealth, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Rick Yang, a director of NeueHealth, Inc., reports the acquisition of warrants to purchase common stock.

Director Edward T. Mathers reports acquisition of warrants for NeueHealth, Inc.

Paul Edward Walker, a director of NeueHealth, Inc., acquired warrants to purchase common stock but disclaims beneficial ownership due to his role in related investment partnerships.

Carmen Chang, a director of NeueHealth, Inc., acquired warrants to purchase common stock on October 1, 2024, as disclosed in a Form 4 filing with the SEC.

Ali Behbahani, a director of NeueHealth, Inc., acquired warrants convertible to common stock on October 1, 2024, with an exercise price of $0.01.

Director Scott D. Sandell reports the acquisition of warrants exercisable for NeueHealth, Inc. common stock, but disclaims beneficial ownership due to his role in various NEA investment partnerships.

Director Mohamad Makhzoumi reports the acquisition of warrants for NeueHealth, Inc. through indirect ownership.

Director Anthony A. Florence Jr. reports acquisition of warrants exercisable for NeueHealth, Inc. common stock, but disclaims beneficial ownership due to indirect holdings through multiple NEA partnerships.

Director Forest Baskett reports the acquisition of warrants for NeueHealth, Inc., exercisable for common stock, through entities managed by NEA.

NEA 18 Venture Growth Equity, L.P. reports the acquisition of warrants and indirect beneficial ownership in NeueHealth, Inc.

New Enterprise Associates 17, L.P. reports acquisition of warrants in NeueHealth, Inc. pursuant to a warrantholders agreement and credit agreement.

New Enterprise Associates 16, L.P. reports acquisition of warrants in NeueHealth, Inc. and indirect beneficial ownership by related entities.

New Enterprise Associates 15, L.P. reports acquisition of warrants in NeueHealth, Inc. on October 1, 2024.

Director Jeffrey Immelt reports the acquisition and disposal of NeueHealth, Inc. common stock and restricted stock units.

Director Manuel Kadre reports acquisition and disposal of NeueHealth, Inc. common stock and restricted stock units.

Director Stephen Kraus reports acquisition and disposal of NeueHealth, Inc. common stock and restricted stock units.

Director Matthew G. Manders of NeueHealth, Inc. reports the acquisition and disposal of common stock and restricted stock units.